Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010578
Filing Date
2017-05-11
Accepted
2017-05-11 17:02:06
Documents
60
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-10q_20170331.htm 10-Q 1125172
2 EX-31.1 cbio-ex311_9.htm EX-31.1 13584
3 EX-31.2 cbio-ex312_8.htm EX-31.2 13671
4 EX-32.1 cbio-ex321_7.htm EX-32.1 9765
5 EX-32.2 cbio-ex322_6.htm EX-32.2 9569
  Complete submission text file 0001564590-17-010578.txt   4428081

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbio-20170331.xml EX-101.INS 903656
7 XBRL TAXONOMY EXTENSION SCHEMA cbio-20170331.xsd EX-101.SCH 35689
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20170331_cal.xml EX-101.CAL 34363
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20170331_def.xml EX-101.DEF 118281
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20170331_lab.xml EX-101.LAB 276540
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20170331_pre.xml EX-101.PRE 228163
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 17835246
SIC: 2834 Pharmaceutical Preparations